Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,772 | -14,287 | -11,494 | -7,634 | -4,037 |
| Depreciation Amortization | 5 | 17 | 13 | 8 | 4 |
| Accounts receivable | 375 | -444 | -284 | -111 | -101 |
| Other Working Capital | -2,053 | -1,228 | -1,590 | -2,063 | -944 |
| Other Operating Activity | -385 | 937 | 962 | 433 | 151 |
| Operating Cash Flow | $-4,830 | $-15,005 | $-12,394 | $-9,367 | $-4,927 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -23 | -23 | -23 | N/A |
| Other Investing Activity | 14 | 37 | 27 | 20 | 3 |
| Investing Cash Flow | $9 | $15 | $5 | $-2 | $3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15 | N/A | N/A | N/A | N/A |
| Debt Repayment | -8 | -7 | -7 | N/A | N/A |
| Common Stock Issued | N/A | 18,764 | 7,991 | 7,986 | 7,584 |
| Financing Cash Flow | $7 | $18,757 | $7,984 | $7,986 | $7,584 |
| Beginning Cash Position | 16,613 | 12,846 | 12,846 | 12,846 | 12,846 |
| End Cash Position | 11,799 | 16,613 | 8,441 | 11,463 | 15,507 |
| Net Cash Flow | $-4,814 | $3,767 | $-4,405 | $-1,383 | $2,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,830 | -15,005 | -12,394 | -9,367 | -4,927 |
| Capital Expenditure | -5 | -23 | -23 | -23 | N/A |
| Free Cash Flow | -4,835 | -15,028 | -12,416 | -9,389 | -4,927 |